GPER1 and hyperaldosteronism: (60) demonstrated that GPER could mediate part of the endothelial inflammatory response induced by aldosterone, suggesting GPER as an alternative target for treating hyperaldosteronism considering the unsatisfactory effect of MR antagonists on cardiovascular risks.